HNB
MRVI icon

Huntington National Bank’s Maravai LifeSciences MRVI Stock Holding History

Huntington National Bank’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-52
Closed -$432 – 4206
2024
Q3 		$432 Hold
52
– – ﹤0.01% 2509
2024
Q2 		$372 Hold
52
– – ﹤0.01% 2471
2024
Q1 		$451 Sell
52
-185
-78% -$1.25K ﹤0.01% 2361
2023
Q4 		$1.55K Buy
+237
New +$1.53K ﹤0.01% 2124
2023
Q3 		– Sell
-273
Closed -$3.39K – 3881
2023
Q2 		$3.39K Sell
273
-20
-7% -$270 ﹤0.01% 1926
2023
Q1 		$4.11K Buy
+293
New +$4.21K ﹤0.01% 1785

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Huntington National Bank's MRVI Position: Q4 2024 in Review

Huntington National Bank sold out of Maravai LifeSciences (MRVI) in Q4 2024, closing a stake of 52 shares — an estimated $432 sold.

Huntington National Bank first reported a position in MRVI in Q1 2023 and held it in 6 quarters. The position peaked at $4.11K in Q1 2023. 185 funds tracked by Wall St. Rank hold MRVI as of Q4 2024.

  • Huntington National Bank reported no remaining Maravai LifeSciences position as of Q4 2024 after selling out during the quarter.
  • Huntington National Bank sold 52 Maravai LifeSciences shares in Q4 2024, an estimated $432.
  • Huntington National Bank first reported a position in Maravai LifeSciences in Q1 2023 and held it in 6 quarters.
  • Huntington National Bank's Maravai LifeSciences position peaked at $4.11K in Q1 2023.
  • 185 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2024.

Based on Huntington National Bank's 13F filing for Q4 2024, filed 12 Feb 2025.